Late recurrence risk in breast cancer differentiated by gene expression test

Patients at higher or lower risk for having their cancer recur elsewhere in the body more than 5 years after diagnosis can be differentiated by a gene expression test. The test measures the expression levels of 58 genes in estrogen receptor-positive breast cancers. These research results were presented at the 5th IMPAKT Breast Cancer Conference in Brussels, Belgium.

Next post in Web Exclusives